Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High frequency chest compression therapy: a case study

S Butler1, B O'Neill

  • 1Physiotherapy Department, Victoria Hospital, London, Ontario, Canada.

Pediatric Pulmonology
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic markers in oesophageal and gastric cancer review. Are they ready for clinical practice?

ESMO gastrointestinal oncology·2026
Same author

Quality-of-Life Analysis of a Phase II Randomised Controlled Trial Comparing Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy in Locally Advanced Rectal Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

sendigR: an R package to leverage the value of CDISC SEND datasets for cross-study analysis.

Frontiers in toxicology·2024
Same author

A comparison between different patient groups for diabetes management during phases of the COVID-19 pandemic: a retrospective cohort study in Ontario, Canada.

BMC primary care·2024
Same author

Carbetocin vs. oxytocin at elective caesarean delivery: challenges and complexities in performing and interpreting a non-inferiority trial.

Anaesthesia·2023
Same author

Biochemically recurrent prostate cancer: rationalisation of the approach to imaging.

Clinical radiology·2023
Same journal

Early Oxygenation Trajectory and Noninvasive Ventilation Failure in Non-Immunocompromised Children With Pediatric ARDS.

Pediatric pulmonology·2026
Same journal

Pulmonary Exacerbations and Treatment in PCD: A Narrative Review.

Pediatric pulmonology·2026
Same journal

Asthma in Children With Congenital Lung Malformations: A Population-Based Case-Control Study.

Pediatric pulmonology·2026
Same journal

Long-Term Effect Of COVID-19 on Children's Lung Function: A Prospective Longitudinal Study.

Pediatric pulmonology·2026
Same journal

Administrative Prevalence and Healthcare Utilization of Pediatric Cystic Fibrosis in a Middle-Income Country: A 10-Year Analysis of National Administrative Data.

Pediatric pulmonology·2026
Same journal

Examining the Placental and Lactational Transfer of Reduced Dose CFTR Modulators in Fetal CF: A Case Report.

Pediatric pulmonology·2026
See all related articles

The ThAIRapy Bronchial Drainage System allows cystic fibrosis patients to self-administer high frequency chest compression (HFCC) for airway clearance. While initial results are positive, further research is needed to confirm its effectiveness and optimal use.

Area of Science:

  • Respiratory Medicine
  • Biomedical Engineering

Background:

  • Cystic Fibrosis (CF) necessitates effective airway clearance techniques.
  • High Frequency Chest Compression (HFCC) is a method to aid mucociliary clearance.

Observation:

  • A novel device, the ThAIRapy Bronchial Drainage System, facilitates self-administered HFCC for CF patients.
  • A case study details a patient's experience using this new system.

Findings:

  • HFCC therapy may enhance mucociliary clearance and lung function in CF patients.
  • Initial patient experience with the ThAIRapy system was positive.
  • Accurate evaluation of the ThAIRapy system's efficacy was not possible in this study.

Implications:

  • The ThAIRapy system offers potential for improved self-management of airway clearance in cystic fibrosis.

Related Experiment Videos

  • Further research is required to establish the efficacy, cost-effectiveness, and treatment guidelines for this device.
  • This technology could represent a significant advancement in respiratory care for CF patients.